<?xml version="1.0" encoding="UTF-8"?>
<p>Statins also interfere with ACE2 signalling. After initial entry through ACE2, SARS-CoV-2 down-regulates ACE2 expression, possibly facilitating the initial infiltration by innate immunity cells and causing an unopposed angiotensin II accumulation, leading to organ injury.
 <xref rid="pvaa042-B1" ref-type="bibr">
  <sup>1</sup>
 </xref> Statins, as well as ARBs, are known to experimentally up-regulate 
 <italic>ACE2</italic> via epigenetic modifications.
 <xref rid="pvaa042-B5" ref-type="bibr">
  <sup>5</sup>
 </xref> (
 <italic>FigureÂ 
  <xref ref-type="fig" rid="pvaa042-F1">1</xref>
 </italic>). Since an increase in ACE2 might prove beneficial for COVID-19 patients, RCTs with recombinant human ACE2 or ARBs are currently underway,
 <xref rid="pvaa042-B1" ref-type="bibr">
  <sup>1</sup>
 </xref> and there is biological plausibility to investigate statins too.
 <xref rid="pvaa042-B5" ref-type="bibr">
  <sup>5</sup>
 </xref>
</p>
